Trade Group Backs Matrixx On Side-Effect Reporting
A federal appeals court was wrong to rule in a class action against Matrixx Initiatives Inc. that drug companies must inform shareholders of all adverse event reports linked to a drug,...To view the full article, register now.
Already a subscriber? Click here to view full article